About this formulation
Research into the role of MOTS-c in cellular metabolism is ongoing and mostly preclinical, and its effects in people have not been established in controlled clinical trials. We make no claims about weight loss, metabolism, exercise capacity or aging.
Ingredient overview
- MOTS-cMitochondrial-derived peptide
Important clinical considerations
No medical benefit is claimed for this preparation. Whether a MOTS-c preparation is appropriate for a patient, and in what form, is a decision for the prescriber based on that patient's clinical needs.
Prescription and eligibility
Available only with a valid prescription written by a licensed prescriber for an individual, identified patient. The pharmacist performs a medication review on every prescription and confirms the details with the prescriber. The prescriber is responsible for verifying that the patient has met all health requirements and is cleared to receive this compounded medication.
Safety disclosures
Compounded medications are not FDA-approved. The FDA has not evaluated this compounded preparation for safety, effectiveness or quality. It is prepared with active pharmaceutical ingredients from FDA-registered manufacturers, for an individual patient pursuant to a valid prescription. This peptide is not an ingredient of any FDA-approved medicine, and its eligibility for 503A compounding is under FDA review. Its effects in people have not been established in controlled clinical trials. Injectable preparations are compounded under USP General Chapter <797> for sterile preparations, and no preparation is released until third-party testing for potency, sterility, pH and endotoxins is complete with passing results. Each preparation comes with an informational brochure on storage and use.
Compounded medications are not FDA-approved. They are prepared with active pharmaceutical ingredients from FDA-registered manufacturers, for individual patients pursuant to a valid prescription from a licensed prescriber.